Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease

计划入组 50 人 · 首次发布于 2026 年 1 月 5 日

French Translation and Validation of the PEYronie's Disease QUESTionnaire

计划入组 30 人 · 首次发布于 2023 年 3 月 14 日

Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease

计划入组 5 人 · 首次发布于 2020 年 3 月 30 日

Aminobenzoic acid

C₇H₇NO₂

Collagenase clostridium histolyticum(Qwo, Santyl, Xiaflex)

Rx

liver disease program

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

Collagenase Clostridium Histolyticum Shows Promise for Ventral Curvature in Peyronie's Disease

Connext Completes Enrollment in Phase 2 Trial of CNT201 for Dupuytren's Contracture

Xiaflex Meets Phase III Primary Endpoint in Plantar Fibromatosis, Setting Stage for First-Ever FDA Approval